Glaucoma neuroprotection with BDNF on the level of retinal and primary visual cortex

2016/23/N/NZ7/02555

Keywords

Descriptors

  • NZ7_4: Prewencja populacyjna

Panel

NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution

Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

Voivodeship: mazowieckie

Other projects carried out by the institution »

Principal investigator (from the host institution)

Anna Wójcik- Gryciuk

Number of co-investigators in the project: 3

Call

PRELUDIUM 12 – announced on 2016-09-15

Amount awarded
150 000 PLN
Project start date
2017-08-29
Project end date
2021-02-27
Project duration
42 months (the same as in the proposal)
Project status
Project settled

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Equipment purchased [PL]

  1. 55-calowy monitor z zakrzywionym ekranem typu OLED. Cost: 7 200 PLN

Information in the final report

Publication in academic press/journals (1)

  1. Neuroprotection of Retinal Ganglion Cells with AAV2-BDNF Pretreatment Restoring Normal TrkB Receptor Protein Levels in Glaucoma

    Authors:
    Anna Wójcik-Gryciuk, Olga Gajewska-Woźniak, Katarzyna Kordecka, Paweł M. Boguszewski, Wioletta Waleszczyk, Małgorzata Skup
    Academic press:
    International Journal of Molecular Sciences (year: 2020, volume: 17, pages: 15), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/ijms21176262 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski